Worst performer was N4P:N4 Pharma which announced the closure of it's re-formulation division and all focus now on its vaccine delivery system. I invested in this company because it had a diverse range of products and so the risk was well spread. Now it is a one product company and the risk has rocketed. Too late to do anything but watch and pray as the shares fell 16% on the announcement this week and are now 84% down. It's not worth taking an £800 loss just to get £200 back so I may as well hang on for the rest of the ride.
SBTX:SkinBioTherapeutics dropped 12% after an absolute fiasco. My faith in OPTI:Optibiotix and CEO Steve O'Hara have been severely dented this week. The price fell from 30p to 20p in a few days, then it appeared some significant investors had been informed of a placing at 19p of shares owned by OPTI:Optibiotix. When asked about this, Steve O'Hara said there was no intention to sell any of OPTI:Optibiotix's shares at this time. Yep - but what about a week ago? The placing was pulled and didn't happen, but not before the share price had crashed to almost the placing price. I knew I should have been merciless with this holding and sold at 30p to buy back later, but I wanted to wait for the announcement of human trials starting. Unfortunately that announcement coincided with the placing invitation so I never got the chance. It doesn't sit well with me and I have concerns given the amount of my portfolio invested in this company. I really hope it was just a cock-up, as until now everything I have seen was in the best interests of shareholders.
KIBO:Kibo Energy dropped 8% after announcing that the Power Purchase Agreement that was meant to be imminent probably isn't going to happen without the government going out to tender. I'm now really worried that they will start to question the development of a coal fired power station when the world is turning away from coal and to renewables. As an environmentalist it doesn't sit well with me that I'm involved in a coal company, but I stand to lose way too much money if I bail out on principle. It makes me pretty certain that I will sell these as soon as I get the chance. However they are 51% down and losing £1,355 at the moment.
RDT:Rosslyn Data are still creeping upwards. This time 6% and they are only 51% down which is a big improvement. Is there hope?
CAML:Central Asia Metals have finally reversed their slide and climbed 8% in what ought to be a steady climb. I'm hoping for the same with CEY:Centamin which also climbed 8% as the gold price recovers.
PAF:Pan African Resources did even better after people realised the drop after interims was over-done, and climbed 10% to go 12% up. However, with the dividend suspended this year I may take some profit and move these elsewhere.
RED:RedT Energy wins Share of the Week climbing 17%. These are now only 7% down and as big orders keep rolling in should become profitable very soon.
Just a slight tick up but the best week for a while.
Here's the ISA and share portfolios
| Weekly Change | |||
| Cash | £6.61 | +£0 | |
| Portfolio cost | £56,958.55 | +£0 | |
| Portfolio sell value (bid price - commission) | £63,152.00 | (10.9%) | +£986.77 |
| Potential profits | £13,569.06 | +£780.42 | |
| Yr 4 Dividends | £29.56 | +£0 | |
| Yr 4 Profit from sales | £814.53 | +£0 | |
| Yr 4 Average monthly cash profit | £517.89 | (10.9%) | -£86.31 |
| Total Dividends | £1,267.89 | +£0 | |
| Total Profit from sales | £19,511.65 | +£0 | |
| Average monthly cash profit | £548.33 | (11.6%) | -£3.38 |
| (Sold stocks profit + Dividends - Fees / Months) |
OPTI:Optibiotix climbed 2p this week which covers the rise in potential profits, and recoveries in CEY:Centamin and RED:RedT Energy helped losses recover by around £200 on top of the increased profits.
As with the overall chart, a nice little tick up
The SIPP looks like this after week 147
| Weekly Change | |||
| Cash | £42.83 | +£0 | |
| Portfolio cost | £27,893.76 | +£0 | |
| Portfolio sell value (bid price - commission) | £32,476.47 | (16.4%) | +£741.31 |
| Potential profits | £7,936.87 | +£903.30 | |
| Yr 3 Dividends | £292.57 | +£0 | |
| Yr 3 Profit from sales | £1,619.73 | +£0 | |
| Yr 3 Average monthly cash profit | £181.55 | (7.8%) | -£4.32 |
| Total Dividends | £1,208.67 | +£0 | |
| Total Profit from sales | £10,544.92 | +£0 | |
| Average monthly cash profit | £338.86 | (14.6%) | -£2.32 |
| (Sold stocks profit + Dividends - Fees / Months) |
Profits up thanks to OPTI:Optibiotix and CAML:Central Asia Metals, but the N4P:N4 Pharma debacle caused losses to deepen and erase some of the good.
Same shape chart as the others
The trading account looks like this after week 113
| Weekly Change | |||
| Cash | £151.47 | +£0 | |
| Portfolio cost | £2,321.29 | +£0 | |
| Portfolio sell value (bid price - commission) | £1,918.45 | (-17.4%) | +£2.28 |
| Potential profits | £108.00 | +£13.44 | |
| Year 3 Dividends | £0 | +£0 | |
| Year 3 Profit | £177.06 | +£0 | |
| Yr 3 Average monthly cash profit | £85.25 | (44.1%) | -£10.66 |
| Dividends | £1.15 | +£0 | |
| Profit from sales | -£64.29 | +£0 | |
| Average monthly cash profit | -£2.42 | (-1.3%) | +£0.02 |
| (Sold stocks profit + Dividends - Fees / Months) |
Well it's all happening here! TAP:Taptica crept up by £13 but deepening losses meant the overall effect was a £2 rise.
Still a long way off working like this is supposed to.
There was an announcement this week from the company that used to be AFPO:African Potash and is now called BLOC:Block Commodities. The shares are suspended as it looks like someone is going to buy them out. Well that's just brilliant - I bought the shares at 2.45p and they are now worth 0.02p. I wonder what I'll get for them - maybe 0.05p? Total disaster, but at least the poxy things will cease to be an embarrassment in my portfolio. My performance will be hammered by a £700 loss though.
That's it - I'm completely knackered after a great weekend of walking, birding, eating and drinking in Norfolk so I can't begin to think what might happen next week. Just want to go to bed...
No comments:
Post a Comment